{"id":309917,"date":"2020-12-14T11:05:09","date_gmt":"2020-12-14T10:05:09","guid":{"rendered":"https:\/\/www.pcnen.com\/portal\/?p=309917"},"modified":"2020-12-14T11:05:09","modified_gmt":"2020-12-14T10:05:09","slug":"novartisov-lijek-neuspjesan-kod-teskih-oblika-kovid-19","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2020\/12\/14\/novartisov-lijek-neuspjesan-kod-teskih-oblika-kovid-19\/","title":{"rendered":"Novartisov lijek neuspje\u0161an kod te\u0161kih oblika kovid-19"},"content":{"rendered":"<p>&#8220;Studija tre\u0107e faze (posljednja faza ispitivanja na ljudima) nije imala o\u010dekivani rezultat po pitanju smanjenja broja hospitalizacija pacijenata sa kovid-19 koji su imali ozbiljne komplikacije&#8221;, saop\u0161tio je Novartis, prenosi Beta.<\/p>\n<p>Ta grupa dodaje da nastavlja sa radom kako bi se analizirali rezultati u cilju boljeg razumijevanja kovid-19.<\/p>\n<p>Grupa precizira da nemogu\u0107nost ruksolitiniba da pobolj\u0161a stanje pacijenata sa kovid-19 &#8220;nije uticala na aktuelna ispitivanja drugih bolesti&#8221;.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u0160vajcarska farmaceutska grupa Novartis je saop\u0161tila danas da klini\u010dka ispitivanja lijeka ruksolitiniba nijesu pokazala pobolj\u0161anje u lije\u010denju te\u0161kih oblika kovid-19.<\/p>\n","protected":false},"author":1,"featured_media":241229,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-309917","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/309917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=309917"}],"version-history":[{"count":1,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/309917\/revisions"}],"predecessor-version":[{"id":309918,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/309917\/revisions\/309918"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media\/241229"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=309917"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=309917"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=309917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}